Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2014

01-06-2014 | Article

Association of genetic variants in estrogen receptor α with HCV infection susceptibility and viral clearance in a high-risk Chinese population

Authors: Shaidi Tang, Ming Yue, Jiajia Wang, Jing Su, Rongbin Yu, Donghui Zhou, Ke Xu, Li Cai, Yun Zhang, Jie Wang

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2014

Login to get access

Abstract

The purpose of this study was to test the hypothesis that genetic variants of estrogen receptor α (ERα) are associated with the outcomes of hepatitis C virus (HCV) infection. We genotyped the seven single nucleotide polymorphisms (SNPs) (rs2077647, rs9340799, rs2234693, rs1801132, rs9322354, rs2228480 and rs3798577) of ERα and conducted a case-control study in a high-risk Chinese population, including 429 HCV spontaneous clearance cases, 880 persistent infection cases and 1,174 uninfected controls. The C allele of rs2234693 was significantly associated with increased susceptibility to HCV infection [dominant model: adjusted odds ratio (OR) = 1.377, 95 % confidence interval (CI) =1.126–1.778], and the risk effect remained significant among the younger (≤55 years) and hemodialysis subjects (all P < 0.007). The other three SNPs variant genotypes also showed significant correlation with elevated risk of HCV infection in different strata (rs2077647 in males; rs9340799 in blood donors; rs1801132 in younger subjects; all P < 0.007). It was also discovered that carriage of rs2228480 A allele was more prone to develop persistent HCV infection (dominant model: adjusted OR = 1.203, 95 % CI = 1.154–1.552), and the risk effect was more evident in females and blood donors (all P < 0.007). Haplotype analyses (rs2077647, rs9340799 and rs2234693) showed that, compared with the most frequent haplotype TAT, CAC played a risk effect in subgroups of younger (P = 3.24 × 10−3) and male (P = 5.51 × 10−4), whereas CAT expressed a protective effect in females (P = 2.27 × 10−4) for HCV infection susceptibility. We first report that these SNPs (rs2077647, rs9340799, rs2234693, rs1801132 and rs2228480) in ERα can influence the outcomes of HCV infection in a high-risk Chinese population.
Literature
1.
go back to reference Cui Y, Jia J (2013) Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol 28(Suppl 1):7–10PubMedCrossRef Cui Y, Jia J (2013) Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol 28(Suppl 1):7–10PubMedCrossRef
3.
4.
go back to reference Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J et al (2001) Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34:730–739PubMedCrossRef Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J et al (2001) Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34:730–739PubMedCrossRef
6.
go back to reference Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M et al (2006) Higher clearance of hepatitis C virus infection in females compared with males. Gut 55:1183–1187PubMedCentralPubMedCrossRef Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M et al (2006) Higher clearance of hepatitis C virus infection in females compared with males. Gut 55:1183–1187PubMedCentralPubMedCrossRef
7.
go back to reference Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V et al (2004) Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 40:1426–1433PubMedCrossRef Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V et al (2004) Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 40:1426–1433PubMedCrossRef
8.
go back to reference Shimizu I, Omoya T, Kondo Y, Kusaka Y, Tsutsui A et al (2001) Estrogen therapy in a male patient with chronic hepatitis C and irradiation-induced testicular dysfunction. Intern Med 40:100–104PubMedCrossRef Shimizu I, Omoya T, Kondo Y, Kusaka Y, Tsutsui A et al (2001) Estrogen therapy in a male patient with chronic hepatitis C and irradiation-induced testicular dysfunction. Intern Med 40:100–104PubMedCrossRef
9.
go back to reference Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T et al (2005) Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon. J Gastroenterol 40:148–156PubMedCrossRef Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T et al (2005) Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon. J Gastroenterol 40:148–156PubMedCrossRef
10.
go back to reference Codes L, Matos L, Parana R (2007) Chronic hepatitis C and fibrosis: evidences for possible estrogen benefits. Braz J Infect Dis 11:371–374PubMedCrossRef Codes L, Matos L, Parana R (2007) Chronic hepatitis C and fibrosis: evidences for possible estrogen benefits. Braz J Infect Dis 11:371–374PubMedCrossRef
11.
go back to reference Mizoguchi Y, Takeda H, Kobayashi K, Morisawa S, Yamamoto S (1989) Estradiol receptors in the cytosol of peripheral blood mononuclear cells in hepatitis virus carriers. Osaka City Med J 35:93–100PubMed Mizoguchi Y, Takeda H, Kobayashi K, Morisawa S, Yamamoto S (1989) Estradiol receptors in the cytosol of peripheral blood mononuclear cells in hepatitis virus carriers. Osaka City Med J 35:93–100PubMed
12.
go back to reference Paharkova-Vatchkova V, Maldonado R, Kovats S (2004) Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors. J Immunol 172:1426–1436PubMedCrossRef Paharkova-Vatchkova V, Maldonado R, Kovats S (2004) Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors. J Immunol 172:1426–1436PubMedCrossRef
13.
go back to reference Suzuki T, Shimizu T, Yu HP, Hsieh YC, Choudhry MA et al (2007) Salutary effects of 17beta-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor-alpha. Am J Physiol Cell Physiol 292:C2103–C2111PubMedCrossRef Suzuki T, Shimizu T, Yu HP, Hsieh YC, Choudhry MA et al (2007) Salutary effects of 17beta-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor-alpha. Am J Physiol Cell Physiol 292:C2103–C2111PubMedCrossRef
14.
go back to reference Karpuzoglu E, Zouali M (2011) The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management. Clin Rev Allergy Immunol 40:16–26PubMedCrossRef Karpuzoglu E, Zouali M (2011) The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management. Clin Rev Allergy Immunol 40:16–26PubMedCrossRef
15.
go back to reference Salem ML (2004) Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 3:97–104PubMedCrossRef Salem ML (2004) Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 3:97–104PubMedCrossRef
16.
go back to reference Cunningham M, Gilkeson G (2011) Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol 40:66–73PubMedCrossRef Cunningham M, Gilkeson G (2011) Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol 40:66–73PubMedCrossRef
17.
go back to reference Yan Z, Tan W, Xu B, Dan Y, Zhao W et al (2011) A cis-acting regulatory variation of the estrogen receptor α (ESR1) gene is associated with hepatitis B virus-related liver cirrhosis. Hum Mutat 32:1128–1136PubMedCrossRef Yan Z, Tan W, Xu B, Dan Y, Zhao W et al (2011) A cis-acting regulatory variation of the estrogen receptor α (ESR1) gene is associated with hepatitis B virus-related liver cirrhosis. Hum Mutat 32:1128–1136PubMedCrossRef
18.
go back to reference Villa E, Colantoni A, Grottola A, Ferretti I, Buttafoco P et al (2002) Variant estrogen receptors and their role in liver disease. Mol Cell Endocrinol 193:65–69PubMedCrossRef Villa E, Colantoni A, Grottola A, Ferretti I, Buttafoco P et al (2002) Variant estrogen receptors and their role in liver disease. Mol Cell Endocrinol 193:65–69PubMedCrossRef
19.
go back to reference Miceli V, Cocciadiferro L, Fregapane M, Zarcone M, Montalto G et al (2011) Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression. Omics J Integr Biol 15:313–317CrossRef Miceli V, Cocciadiferro L, Fregapane M, Zarcone M, Montalto G et al (2011) Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression. Omics J Integr Biol 15:313–317CrossRef
20.
go back to reference Zuppan P, Hall JM, Lee MK, Ponglikitmongkol M, King MC (1991) Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am J Hum Genet 48:1065–1068PubMedCentralPubMed Zuppan P, Hall JM, Lee MK, Ponglikitmongkol M, King MC (1991) Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am J Hum Genet 48:1065–1068PubMedCentralPubMed
21.
go back to reference Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE et al (2008) Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 17:2293–2309PubMedCentralPubMedCrossRef Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE et al (2008) Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 17:2293–2309PubMedCentralPubMedCrossRef
22.
go back to reference Lian K, Lui L, Zmuda JM, Nevitt MC, Hochberg MC et al (2007) Estrogen receptor alpha genotype is associated with a reduced prevalence of radiographic hip osteoarthritis in elderly Caucasian women. Osteoarthr Cartil 15:972–978PubMedCentralPubMedCrossRef Lian K, Lui L, Zmuda JM, Nevitt MC, Hochberg MC et al (2007) Estrogen receptor alpha genotype is associated with a reduced prevalence of radiographic hip osteoarthritis in elderly Caucasian women. Osteoarthr Cartil 15:972–978PubMedCentralPubMedCrossRef
23.
go back to reference Yaffe K, Lindquist K, Sen S, Cauley J, Ferrell R et al (2009) Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the health ABC study. Neurobiol Aging 30:607–614PubMedCentralPubMedCrossRef Yaffe K, Lindquist K, Sen S, Cauley J, Ferrell R et al (2009) Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the health ABC study. Neurobiol Aging 30:607–614PubMedCentralPubMedCrossRef
24.
go back to reference Shen C, Chen J, Fan S, Li Z, Hu Y et al (2012) Association between the polymorphism of estrogen receptor alpha and coronary artery disease in a Chinese population. Eur J Intern Med 23:175–178PubMedCrossRef Shen C, Chen J, Fan S, Li Z, Hu Y et al (2012) Association between the polymorphism of estrogen receptor alpha and coronary artery disease in a Chinese population. Eur J Intern Med 23:175–178PubMedCrossRef
25.
go back to reference Boada M, Antunez C, Lopez-Arrieta J, Caruz A, Moreno-Rey C et al (2012) Estrogen receptor alpha gene variants are associated with Alzheimer’s disease. Neurobiol Aging 33(198):e115–e124 Boada M, Antunez C, Lopez-Arrieta J, Caruz A, Moreno-Rey C et al (2012) Estrogen receptor alpha gene variants are associated with Alzheimer’s disease. Neurobiol Aging 33(198):e115–e124
26.
go back to reference Deng G, Zhou G, Zhai Y, Li S, Li X et al (2004) Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 40:318–326PubMedCrossRef Deng G, Zhou G, Zhai Y, Li S, Li X et al (2004) Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 40:318–326PubMedCrossRef
27.
go back to reference Yan Z, Tan W, Dan Y, Zhao W, Deng C et al (2012) Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population. BMC Med Genet 13:49PubMedCentralPubMedCrossRef Yan Z, Tan W, Dan Y, Zhao W, Deng C et al (2012) Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population. BMC Med Genet 13:49PubMedCentralPubMedCrossRef
28.
go back to reference Zhai Y, Zhou G, Deng G, Xie W, Dong X et al (2006) Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Gastroenterology 130:2001–2009PubMedCrossRef Zhai Y, Zhou G, Deng G, Xie W, Dong X et al (2006) Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Gastroenterology 130:2001–2009PubMedCrossRef
30.
go back to reference Puoti C, Guarisco R, Bellis L, Spilabotti L (2009) Diagnosis, management, and treatment of hepatitis C. Hepatology 50(322):324–325 Puoti C, Guarisco R, Bellis L, Spilabotti L (2009) Diagnosis, management, and treatment of hepatitis C. Hepatology 50(322):324–325
31.
go back to reference Bhattacherjee V, Prescott LE, Pike I, Rodgers B, Bell H et al (1995) Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol 76:1737–1748PubMedCrossRef Bhattacherjee V, Prescott LE, Pike I, Rodgers B, Bell H et al (1995) Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol 76:1737–1748PubMedCrossRef
32.
go back to reference Gaunt TR, Rodriguez S, Day IN (2007) Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool ‘CubeX’. BMC Bioinforma 8:428CrossRef Gaunt TR, Rodriguez S, Day IN (2007) Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool ‘CubeX’. BMC Bioinforma 8:428CrossRef
33.
go back to reference Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169PubMedCentralPubMedCrossRef Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169PubMedCentralPubMedCrossRef
34.
go back to reference Shimizu I, Kohno N, Tamaki K, Shono M, Huang HW et al (2007) Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J Gastroenterol 13:4295–4305PubMed Shimizu I, Kohno N, Tamaki K, Shono M, Huang HW et al (2007) Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J Gastroenterol 13:4295–4305PubMed
35.
go back to reference Watashi K, Inoue D, Hijikata M, Goto K, Aly HH et al (2007) Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B. J Biol Chem 282:32765–32772PubMedCrossRef Watashi K, Inoue D, Hijikata M, Goto K, Aly HH et al (2007) Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B. J Biol Chem 282:32765–32772PubMedCrossRef
36.
go back to reference Hsiao WC, Young KC, Lin SL, Lin PW (2004) Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study. Breast Cancer Res 6:R180–R186PubMedCentralPubMedCrossRef Hsiao WC, Young KC, Lin SL, Lin PW (2004) Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study. Breast Cancer Res 6:R180–R186PubMedCentralPubMedCrossRef
37.
go back to reference Riancho JA (2006) A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density. Eur J Endocrinol 155:53–59PubMedCrossRef Riancho JA (2006) A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density. Eur J Endocrinol 155:53–59PubMedCrossRef
38.
go back to reference Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X et al (2002) Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105:1879–1882PubMedCrossRef Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X et al (2002) Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105:1879–1882PubMedCrossRef
39.
go back to reference Long JR, Xu H, Zhao LJ, Liu PY, Shen H et al (2005) The oestrogen receptor alpha gene is linked and/or associated with age of menarche in different ethnic groups. J Med Genet 42:796–800PubMedCentralPubMedCrossRef Long JR, Xu H, Zhao LJ, Liu PY, Shen H et al (2005) The oestrogen receptor alpha gene is linked and/or associated with age of menarche in different ethnic groups. J Med Genet 42:796–800PubMedCentralPubMedCrossRef
40.
go back to reference Ghosh J, Joshi G, Pradhan S, Mittal B (2012) Potential role of aromatase over estrogen receptor gene polymorphisms in migraine susceptibility: a case control study from North India. PLoS One 7:e34828PubMedCentralPubMedCrossRef Ghosh J, Joshi G, Pradhan S, Mittal B (2012) Potential role of aromatase over estrogen receptor gene polymorphisms in migraine susceptibility: a case control study from North India. PLoS One 7:e34828PubMedCentralPubMedCrossRef
41.
go back to reference Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B (2012) Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One 7:e40162PubMedCentralPubMedCrossRef Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B (2012) Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One 7:e40162PubMedCentralPubMedCrossRef
42.
go back to reference Li N, Dong J, Hu Z, Shen H, Dai M (2010) Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121:177–184PubMedCrossRef Li N, Dong J, Hu Z, Shen H, Dai M (2010) Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121:177–184PubMedCrossRef
43.
44.
go back to reference Yang J, Singleton DW, Shaughnessy EA, Khan SA (2008) The F-domain of estrogen receptor-alpha inhibits ligand induced receptor dimerization. Mol Cell Endocrinol 295:94–100PubMedCrossRef Yang J, Singleton DW, Shaughnessy EA, Khan SA (2008) The F-domain of estrogen receptor-alpha inhibits ligand induced receptor dimerization. Mol Cell Endocrinol 295:94–100PubMedCrossRef
45.
go back to reference Anghel A, Narita D, Seclaman E, Popovici E, Anghel M et al (2010) Estrogen receptor alpha polymorphisms and the risk of malignancies. Pathol Oncol Res 16:485–496PubMedCrossRef Anghel A, Narita D, Seclaman E, Popovici E, Anghel M et al (2010) Estrogen receptor alpha polymorphisms and the risk of malignancies. Pathol Oncol Res 16:485–496PubMedCrossRef
46.
go back to reference Thursz M (2004) Pros and cons of genetic association studies in hepatitis B. Hepatology 40:284–286PubMedCrossRef Thursz M (2004) Pros and cons of genetic association studies in hepatitis B. Hepatology 40:284–286PubMedCrossRef
Metadata
Title
Association of genetic variants in estrogen receptor α with HCV infection susceptibility and viral clearance in a high-risk Chinese population
Authors
Shaidi Tang
Ming Yue
Jiajia Wang
Jing Su
Rongbin Yu
Donghui Zhou
Ke Xu
Li Cai
Yun Zhang
Jie Wang
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2014
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-013-2038-y

Other articles of this Issue 6/2014

European Journal of Clinical Microbiology & Infectious Diseases 6/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine